The Effect of Tang Ning Tongluo Formula in Type 2 Diabetics Clinical Analysis

Clinical trial NCT02174042 · COMPLETED

Trial details

NCT number: NCT02174042
Sponsor: Guizhou Bailing Group Pharmaceutical Co Ltd
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

General Disorders and Administration Site Conditions

Start date: 2014-03-01
Primary completion: 2014-08-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.